Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen vs hormone replacement for endometrial preparation in thin endometrium FET cycles
ChiCTR2100043820Phase 4Recruiting
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tamoxifen and estradiol valerate in infertility and Endometrial hypotrophy (2 arms), sponsored by Zhejiang Provincial People's Hospital. Primary endpoints: Clinical pregnancy rate and Live birth rate. Started Mar 2021; status: recruiting.
02
Drugs
tamoxifenestradiol valerate
03
Conditions
infertilityEndometrial hypotrophy
Beyond the preview
Go deeper on ChiCTR2100043820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043820.